These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35037466)

  • 21. Early treatment with 2-deoxy-d-glucose reduces proliferative proteins in the kidney and slows cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (PKD).
    Atwood D; He Z; Miyazaki M; Hailu F; Klawitter J; Edelstein CL
    Cell Signal; 2024 Nov; 123():111351. PubMed ID: 39159908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes.
    Malas TB; Formica C; Leonhard WN; Rao P; Granchi Z; Roos M; Peters DJ; 't Hoen PA
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F806-F817. PubMed ID: 28148532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA
    Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
    J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
    Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
    Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.
    Olsan EE; West JD; Torres JA; Doerr N; Weimbs T
    Am J Physiol Renal Physiol; 2018 Jul; 315(1):F86-F96. PubMed ID: 29513071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
    Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
    Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
    Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
    Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice.
    Chang MY; Tsai CY; Chou LF; Hsu SH; Yang HY; Hung CC; Tian YC; Ong ACM; Yang CW
    Hum Mol Genet; 2022 May; 31(10):1560-1573. PubMed ID: 34957500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease.
    Yoo M; Haydak JC; Azeloglu EU; Lee K; Gusella GL
    J Am Soc Nephrol; 2024 Apr; 35(4):466-482. PubMed ID: 38247039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
    Krappitz M; Bhardwaj R; Dong K; Staudner T; Yilmaz DE; Pioppini C; Westergerling P; Ruemmele D; Hollmann T; Nguyen TA; Cai Y; Gallagher AR; Somlo S; Fedeles S
    J Am Soc Nephrol; 2023 Jan; 34(1):110-121. PubMed ID: 36270750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 34. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
    Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
    Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.
    Al-Hamed MH; Alsahan N; Rice SJ; Edwards N; Nooreddeen E; Alotaibi M; Kurdi W; Alnemer M; Altaleb N; Ali W; Al-Numair N; Almejaish N; Sayer JA; Imtiaz F
    Pediatr Nephrol; 2019 Sep; 34(9):1615-1623. PubMed ID: 31079206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease.
    Zhou JX; Li LX; Zhang H; Agborbesong E; Harris PC; Calvet JP; Li X
    Kidney Int; 2024 Aug; 106(2):258-272. PubMed ID: 38782200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
    He WB; Xiao WJ; Tan YQ; Zhao XM; Li W; Zhang QJ; Zhong CG; Li XR; Hu L; Lu GX; Lin G; Du J
    BMC Med Genet; 2018 Oct; 19(1):186. PubMed ID: 30333007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
    Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.